A single ascending dose study of the novel GLP-1 receptor agonist GL0034 (utreglutide) in individuals with obesity without diabetes

R. Thennati; V. Burade; M. Natarajan; P. Shahi; R. Nagaraja; S. Panchal; S. Agrawal; B. Jandrain; T. Duvauchelle; A. Garcia-Ocana; G. A. Rutter; R. E. Pratley; B. Thorens; T. Vilsboll

doi:10.1007/s00125-023-05969-6

A single ascending dose study of the novel GLP-1 receptor agonist GL0034 (utreglutide) in individuals with obesity without diabetes

R. Thennati, V. Burade, M. Natarajan, P. Shahi, R. Nagaraja, S. Panchal, S. Agrawal, B. Jandrain, T. Duvauchelle, A. Garcia-Ocana, G. A. Rutter, R. E. Pratley, B. Thorens, T. Vilsboll

Steno Diabetes Center Copenhagen

2 Citations (Scopus)

Original language	English
Journal	Diabetologia
Volume	66
Issue number	SUPPL 1, 1
Pages (from-to)	S320-S321
ISSN	0012-186X
DOIs	https://doi.org/10.1007/s00125-023-05969-6
Publication status	Published - 1 Sept 2023
Event	59th EASD Annual Meeting: EASD 2023 - Hamburg Exhibition and Congress, Hamborg, Germany Duration: 2 Oct 2023 → 6 Oct 2023 Conference number: 59 https://www.easd.org/annual-meeting/easd-2023.html

Conference

Conference	59th EASD Annual Meeting: EASD 2023
Number	59
Location	Hamburg Exhibition and Congress
Country/Territory	Germany
City	Hamborg
Period	02/10/2023 → 06/10/2023
Internet address	https://www.easd.org/annual-meeting/easd-2023.html

Access to Document

10.1007/s00125-023-05969-6

Cite this

Thennati, R., Burade, V., Natarajan, M., Shahi, P., Nagaraja, R., Panchal, S., Agrawal, S., Jandrain, B., Duvauchelle, T., Garcia-Ocana, A., Rutter, G. A., Pratley, R. E., Thorens, B., & Vilsboll, T. (2023). A single ascending dose study of the novel GLP-1 receptor agonist GL0034 (utreglutide) in individuals with obesity without diabetes. Diabetologia, 66(SUPPL 1, 1), S320-S321. https://doi.org/10.1007/s00125-023-05969-6

Thennati, R, Burade, V, Natarajan, M, Shahi, P, Nagaraja, R, Panchal, S, Agrawal, S, Jandrain, B, Duvauchelle, T, Garcia-Ocana, A, Rutter, GA, Pratley, RE, Thorens, B & Vilsboll, T 2023, 'A single ascending dose study of the novel GLP-1 receptor agonist GL0034 (utreglutide) in individuals with obesity without diabetes', Diabetologia, vol. 66, no. SUPPL 1, 1, pp. S320-S321. https://doi.org/10.1007/s00125-023-05969-6

@article{1b37436e8c88403e8be4b39ec89bfa61,

title = "A single ascending dose study of the novel GLP-1 receptor agonist GL0034 (utreglutide) in individuals with obesity without diabetes",

author = "R. Thennati and V. Burade and M. Natarajan and P. Shahi and R. Nagaraja and S. Panchal and S. Agrawal and B. Jandrain and T. Duvauchelle and A. Garcia-Ocana and Rutter, \{G. A.\} and Pratley, \{R. E.\} and B. Thorens and T. Vilsboll",

note = "59th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), Hamburg, GERMANY, OCT 02-06, 2023; 59th EASD Annual Meeting: EASD 2023, EASD 2023 ; Conference date: 02-10-2023 Through 06-10-2023",

year = "2023",

month = sep,

day = "1",

doi = "10.1007/s00125-023-05969-6",

language = "English",

volume = "66",

pages = "S320--S321",

journal = "Diabetologia",

issn = "0012-186X",

publisher = "Springer Science and Business Media Deutschland GmbH",

number = "SUPPL 1, 1",

url = "https://www.easd.org/annual-meeting/easd-2023.html",

}

TY - ABST

T1 - A single ascending dose study of the novel GLP-1 receptor agonist GL0034 (utreglutide) in individuals with obesity without diabetes

AU - Thennati, R.

AU - Burade, V.

AU - Natarajan, M.

AU - Shahi, P.

AU - Nagaraja, R.

AU - Panchal, S.

AU - Agrawal, S.

AU - Jandrain, B.

AU - Duvauchelle, T.

AU - Garcia-Ocana, A.

AU - Rutter, G. A.

AU - Pratley, R. E.

AU - Thorens, B.

AU - Vilsboll, T.

N1 - Conference code: 59

PY - 2023/9/1

Y1 - 2023/9/1

UR - https://www.scopus.com/pages/publications/85171807264

U2 - 10.1007/s00125-023-05969-6

DO - 10.1007/s00125-023-05969-6

M3 - Conference abstract in journal

SN - 0012-186X

VL - 66

SP - S320-S321

JO - Diabetologia

JF - Diabetologia

IS - SUPPL 1, 1

T2 - 59th EASD Annual Meeting: EASD 2023

Y2 - 2 October 2023 through 6 October 2023

ER -

A single ascending dose study of the novel GLP-1 receptor agonist GL0034 (utreglutide) in individuals with obesity without diabetes

Conference

Access to Document

Other files and links

Cite this